* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Saturday, May 17, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Alabama to expand Entertainment Industry Incentive Act – WVTM

    Alabama Boosts Entertainment Industry with Expanded Incentive Act!

    Toast Sets Its Sights on Revolutionizing Entertainment Venues

    Eva Dickerman Joins Entertainment 360 As Partner – Deadline

    Eva Dickerman Takes the Spotlight as New Partner at Entertainment 360!

    Avid Appoints Act Entertainment as U.S. Distributor for Its Live Sound Portfolio – TVTechnology

    Avid Teams Up with Act Entertainment to Bring Live Sound Innovations to the U.S. Market!

    Rambo Origin Movie in the Works, First Plot Details Revealed – Yahoo

    Get Ready for Action: Exciting Plot Details Unveiled for the Upcoming Rambo Origin Movie!

    Skybound Acquires Digital Talent Firm Nine Four Entertainment – Variety

    Skybound Expands Its Horizons with Acquisition of Digital Talent Firm Nine Four Entertainment

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Stony Brook Medicine Pioneers Use of AI Technology for Heart Disease Diagnosis on Long Island – SBU News

    Revolutionizing Heart Health: Stony Brook Medicine Leads the Way with AI Technology

    How to Clean Up and Restore Low-Quality Videos with AI Technology – finehomesandliving.com

    How to Clean Up and Restore Low-Quality Videos with AI Technology – finehomesandliving.com

    Opening kids’ eyes to the wonders of Information and Communication Technology at EBU Girls in ICT Day 2025 – EBU tech

    Unleashing Curiosity: Exploring the Magic of Information and Communication Technology at EBU Girls in ICT Day 2025!

    Senate confirm Meink, an aerospace engineer, as USAF Secretary – Air Force Technology

    Senate Approves Aerospace Engineer Meink as New Secretary of the Air Force!

    ‘Technology is always key’: Alachua County Sheriff’s Office plans new ‘Crime Intelligence Center’ – WCJB TV20

    Unlocking Safety: Alachua County Sheriff’s Office Unveils Innovative ‘Crime Intelligence Center

    Charter Names Jake Perlman EVP, Chief Technology & Information Officer – TVTechnology

    Charter Names Jake Perlman EVP, Chief Technology & Information Officer – TVTechnology

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Alabama to expand Entertainment Industry Incentive Act – WVTM

    Alabama Boosts Entertainment Industry with Expanded Incentive Act!

    Toast Sets Its Sights on Revolutionizing Entertainment Venues

    Eva Dickerman Joins Entertainment 360 As Partner – Deadline

    Eva Dickerman Takes the Spotlight as New Partner at Entertainment 360!

    Avid Appoints Act Entertainment as U.S. Distributor for Its Live Sound Portfolio – TVTechnology

    Avid Teams Up with Act Entertainment to Bring Live Sound Innovations to the U.S. Market!

    Rambo Origin Movie in the Works, First Plot Details Revealed – Yahoo

    Get Ready for Action: Exciting Plot Details Unveiled for the Upcoming Rambo Origin Movie!

    Skybound Acquires Digital Talent Firm Nine Four Entertainment – Variety

    Skybound Expands Its Horizons with Acquisition of Digital Talent Firm Nine Four Entertainment

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Stony Brook Medicine Pioneers Use of AI Technology for Heart Disease Diagnosis on Long Island – SBU News

    Revolutionizing Heart Health: Stony Brook Medicine Leads the Way with AI Technology

    How to Clean Up and Restore Low-Quality Videos with AI Technology – finehomesandliving.com

    How to Clean Up and Restore Low-Quality Videos with AI Technology – finehomesandliving.com

    Opening kids’ eyes to the wonders of Information and Communication Technology at EBU Girls in ICT Day 2025 – EBU tech

    Unleashing Curiosity: Exploring the Magic of Information and Communication Technology at EBU Girls in ICT Day 2025!

    Senate confirm Meink, an aerospace engineer, as USAF Secretary – Air Force Technology

    Senate Approves Aerospace Engineer Meink as New Secretary of the Air Force!

    ‘Technology is always key’: Alachua County Sheriff’s Office plans new ‘Crime Intelligence Center’ – WCJB TV20

    Unlocking Safety: Alachua County Sheriff’s Office Unveils Innovative ‘Crime Intelligence Center

    Charter Names Jake Perlman EVP, Chief Technology & Information Officer – TVTechnology

    Charter Names Jake Perlman EVP, Chief Technology & Information Officer – TVTechnology

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Science

An effective MASH drug is good, but biotech can make it better

May 8, 2024
in Science
An effective MASH drug is good, but biotech can make it better
Share on FacebookShare on Twitter

Understanding this complex disease requires better model systems and large-scale data.

The US Food and Drug Administration recently approved Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) in adults. The new drug is a groundbreaking win for a disease with no previous therapy. MASH, previously known as noncirrhotic non-alcoholic steatohepatitis (NASH), occurs when excess fat cells build up in the liver, leading to inflammation, scarring and possible liver failure. It affects 1.5–6.45% of the worldwide population.

MASH has sorely tested biopharma’s tenacity and ingenuity. Over the past two decades, pharma and biotech companies globally have attempted — and failed — to develop drugs. The search for an effective drug has frustrated companies, investors and patients. Novo Nordisk, Eli Lilly, Pfizer and AstraZeneca have all tried their own MASH drugs against different pathways; some are still in phase 2 and 3 trials1, but many have been pulled in recent years when not enough positive effect was seen compared with placebo. Big pharma also has the new glucagon-like peptide-1 (GLP-1) agonists, which are being trialed to see whether they can be used against MASH. Results so far are promising, which is expected, as weight loss is the primary treatment suggested for reducing MASH progression. Considering the many failed attempts, the approval of Resmetirom is noteworthy. But as a drug, it is far from ideal: only 25–30% of patients with MASH benefit from treatment.

The main problem is that we have yet to understand the molecular mechanisms underpinning the disease. MASH is complex, and there is much to still learn about the pathways involved2. We know that it is a metabolic disorder characterized by dysregulation of glucose, lipid and bile acid metabolism. Fats accumulate in the liver and other peripheral tissues, eventually leading to liver fibrosis. However, MASH varies in its progression between individuals, and there are several layers of metabolic, genetic and epigenetic pathway changes. As a result, drugs have been developed against intermediate targets in lipid metabolism, inflammatory responses or fibrotic progression. Phase 3 clinical trial endpoints are either reduction of fatty acid accumulation or reversal in progression of fibrosis. These mitigate the end pathologies but do not necessarily to tackle disease initiation or early-stage progression.

We also lack validated biomarkers for easy or early MASH screening. Resmetirom is a thyroid hormone receptor-β (THRβ) agonist that reduces liver fibrosis, perhaps by boosting the ability of hepatocytes to burn lipids3, but we do not even know for sure how it works.

Most MASH studies are in mice, in which MASH is induced by high-fat, high carbohydrate ‘Western’ diets. Researchers cannot use cell lines or organoids because MASH development depends on the microenvironment of the liver and the metabolic response of an individual. However, the type of diet and amount of fat is critical for modeling disease progression. Diets high in different sugars, for instance, lead to varied disease phenotypes. Genetics can play a part, too, as some mouse models, such as the Foz/Foz mutant strain, develop MASH after 4–8 weeks of a Western diet rather than 16 weeks in wild type4.

Humanized mouse models, containing both human and mouse liver cells, may be better placed to tell us something about the early stages of the disease. In these chimeras, the human liver cells develop a metabolic state consistent with human fatty liver disease whereas the mouse liver cells remain normal5. The limitation here is that these mice also lack immune systems, so the inflammatory response associated with MASH in humans is missing.

While these models have been scientifically informative, they have proven impractical when screening for drug responses. Researchers usually have to repeat their experiments in multiple mouse models to show that the results are independent of any specific model6. In addition, in humans, MASH develops over years, not weeks.

In this age of big ’omics data, can we do better? First, we need a solid understanding of the biology that underlies the development of the disease. We need a global picture of the transcriptomic, proteomic and metabolic changes that occur at each stage of the disease. This disease progression in mice is often heterogeneous — but it is that way in humans too. Instead of trying to make a ‘one size fits all’ mouse model, why not capitalize on this heterogeneity and find ways to target populations at different stages, with different manifestations of MASH? Companies need practical solutions to screen for drugs that will affect the disease at each of these stages.

Some biotech companies are already thinking about this. One approach is from Gordian Biotechnology, which is looking at MASH and other complex diseases related to aging. Gordian’s mosaic screening combines gene therapy with single-cell sequencing and enables multiple drugs to be investigated in a single animal (for MASH, typically mouse or primate, but they use horse or primate models for other aging conditions). Multiple drugs can be barcoded and delivered to an organ and localized responses to each drug analyzed. Looking across a variety of animals could provide information on which drugs work best, in what phenotypes. Machine learning will also be helpful here.

Other companies are looking to move past the ‘one target, one drug’ approach and use more human-based models. Ochre Bio is developing RNA therapies targeted to the liver, using deep phenotyping of human-centric translational models. Cellarity has realized that a complex disease will likely need multiple protein targets and is using single-cell transcriptomics data combined with large perturbation datasets from human samples to find small molecules that could influence disease pathways.

The industry also needs to be more aware of patients and their disease stage during clinical trials. Often, people with MASH have comorbidities that can compromise trial results and lead to response heterogeneity. We know that obesity and type 2 diabetes are risk factors for MASH, but we do not know the exact interplay between the conditions. There need to be enough participants and the trials must be long enough to show an effect in this slow-evolving disease. Looking at endpoints, it takes over a year to see fibrosis disappear. Furthermore, liver biopsies are the only way to measure progression without clear biomarkers, and biopsies are invasive.

While it is possible that GLP-1 agonists may help MASH at early stages, there are still uncertainties around their long-term use, and MASH is a long-term disease. Biopharma has failed in its attempt to find a ‘one size fits all’ solution, but companies can do better if they stop trying to cure the symptoms and instead try to understand the underlying pathology.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Nature.com – https://www.nature.com/articles/s41587-024-02265-5

Tags: BiotechEffectivescience
Previous Post

Sorry Apple faithful, there won’t be any stickers in the new iPad boxes

Next Post

Raiders Trade Rumors: LV ‘Did Not Want to Reach’ for Michael Penix Jr. in NFL Draft

Ecology invests $53.5 million to help rivers and streams – Department of Ecology – State of Washington (.gov)

Transforming Our Waters: $53.5 Million Investment to Revitalize Rivers and Streams

May 17, 2025
North America’s ‘broken heart’: The billion-year-old scar from when the continent nearly ripped apart – Live Science

North America’s ‘broken heart’: The billion-year-old scar from when the continent nearly ripped apart – Live Science

May 17, 2025
AI Discovers Suspected Trigger of Alzheimer’s, And Maybe a Treatment – ScienceAlert

Breakthrough Discovery: AI Uncovers Potential Alzheimer’s Trigger and Treatment!

May 17, 2025
Complement 1 Secures $16M Seed Round to Scale Clinically Validated Cancer Lifestyle Modification Platform – GlobeNewswire

Complement 1 Raises $16M to Revolutionize Cancer Lifestyle Solutions

May 17, 2025
World’s Highest-Paid Athletes – Forbes

World’s Highest-Paid Athletes – Forbes

May 17, 2025
U.K. Economy Raced at Start of Year But Slowdown Looms – WSJ

U.K. Economy Raced at Start of Year But Slowdown Looms – WSJ

May 17, 2025
Alabama to expand Entertainment Industry Incentive Act – WVTM

Alabama Boosts Entertainment Industry with Expanded Incentive Act!

May 17, 2025
Homeless hotel closed for health violations reopens – WCAX

Revitalized and Ready: Formerly Closed Homeless Hotel Reopens After Health Violations

May 17, 2025
A timeline of the Trump administration’s evolving approach to Russia-Ukraine peace talks – CNN

Tracing the Shifting Strategies of the Trump Administration in Russia-Ukraine Peace Talks

May 17, 2025
Stony Brook Medicine Pioneers Use of AI Technology for Heart Disease Diagnosis on Long Island – SBU News

Revolutionizing Heart Health: Stony Brook Medicine Leads the Way with AI Technology

May 17, 2025

Categories

Archives

May 2025
MTWTFSS
 1234
567891011
12131415161718
19202122232425
262728293031 
« Apr    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (616)
  • Economy (627)
  • Entertainment (21,541)
  • General (15,222)
  • Health (9,669)
  • Lifestyle (632)
  • News (22,149)
  • People (631)
  • Politics (635)
  • Science (15,851)
  • Sports (21,137)
  • Technology (15,618)
  • World (617)

Recent News

Ecology invests $53.5 million to help rivers and streams – Department of Ecology – State of Washington (.gov)

Transforming Our Waters: $53.5 Million Investment to Revitalize Rivers and Streams

May 17, 2025
North America’s ‘broken heart’: The billion-year-old scar from when the continent nearly ripped apart – Live Science

North America’s ‘broken heart’: The billion-year-old scar from when the continent nearly ripped apart – Live Science

May 17, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version